Cerulean Pharma (CERU) Tops Q3 EPS by 5c

November 4, 2016 8:30 AM EDT
Get Alerts CERU Hot Sheet
Trade CERU Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Cerulean Pharma (NASDAQ: CERU) reported Q3 EPS of ($0.36), $0.05 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Cerulean Pharma (CERU) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment